CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing lipid-based nanoparticle systems for delivering messenger RNA to treat severe ocular diseases. By enhancing the stability and cellular entry of mRNA, it aims to provide effective therapies for conditions like retinal degenerations and uveitis through eye drops or injections.
Many severe ocular diseases lead to visual impairment and blindness in millions of patients worldwide, and the number is rapidly growing in aging populations.
Most ocular diseases are still without drug treatment and the current treatments are based on the use of small molecules and protein drugs.
However, poor ocular absorption and rapid elimination restrict their development and use in ophthalmology.Technology for mRNA transfer into the cornea and retina and subsequent expression of encoded pr…
UNIVERSITY OF EASTERN FINLAND (UEF)
ITA-SUOMEN YLIOPISTO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Finland, HELSINGIN YLIOPISTO
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Padova
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
